These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8968879)

  • 1. Rabbit model for Chlamydia pneumoniae infection.
    Fong IW; Chiu B; Viira E; Fong MW; Jang D; Mahony J
    J Clin Microbiol; 1997 Jan; 35(1):48-52. PubMed ID: 8968879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental rabbit models of Chlamydia pneumoniae infection.
    Moazed TC; Kuo C; Patton DL; Grayston JT; Campbell LA
    Am J Pathol; 1996 Feb; 148(2):667-76. PubMed ID: 8579129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?
    Fong IW; Chiu B; Viira E; Jang D; Fong MW; Peeling R; Mahony JB
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):891-4. PubMed ID: 10548582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.
    Fong IW; Chiu B; Viira E; Jang D; Mahony JB
    Infect Immun; 1999 Nov; 67(11):6048-55. PubMed ID: 10531266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.
    Fong IW; Chiu B; Viira E; Jang D; Mahony JB
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2321-6. PubMed ID: 12121899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
    Muhlestein JB; Anderson JL; Hammond EH; Zhao L; Trehan S; Schwobe EP; Carlquist JF
    Circulation; 1998 Feb; 97(7):633-6. PubMed ID: 9495296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for Chlamydia pneumoniae infection.
    Saikku P; Laitinen K; Leinonen M
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S17-9. PubMed ID: 9859920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.
    Laitinen K; Laurila A; Pyhälä L; Leinonen M; Saikku P
    Infect Immun; 1997 Nov; 65(11):4832-5. PubMed ID: 9353072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of animal models for Chlamydia pneumoniae-related atherosclerosis.
    Fong IW
    Am Heart J; 1999 Nov; 138(5 Pt 2):S512-3. PubMed ID: 10539861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.
    Coombes BK; Chiu B; Fong IW; Mahony JB
    J Infect Dis; 2002 Jun; 185(11):1621-30. PubMed ID: 12023768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on the mechanisms of Chlamydia pneumoniae respiratory infection in mice with former chlamydial exposure].
    Kimura M
    Kansenshogaku Zasshi; 1994 Jan; 68(1):50-8. PubMed ID: 8138679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature.
    Gieffers J; van Zandbergen G; Rupp J; Sayk F; Krüger S; Ehlers S; Solbach W; Maass M
    Eur Respir J; 2004 Apr; 23(4):506-10. PubMed ID: 15083745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.
    Kuo CC; Gown AM; Benditt EP; Grayston JT
    Arterioscler Thromb; 1993 Oct; 13(10):1501-4. PubMed ID: 7691166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis.
    Shi Y; Tokunaga O
    Pathol Int; 2002 Dec; 52(12):755-63. PubMed ID: 12588444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice.
    Tiirola T; Erkkilä L; Laitinen K; Leinonen M; Saikku P; Bloigu A; Jauhiainen M
    Scand J Clin Lab Invest; 2002; 62(6):477-84. PubMed ID: 12469903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine models of Chlamydia pneumoniae infection and atherosclerosis.
    Moazed TC; Kuo C; Grayston JT; Campbell LA
    J Infect Dis; 1997 Apr; 175(4):883-90. PubMed ID: 9086145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro infection of smooth muscle cells by Chlamydia pneumoniae.
    Knoebel E; Vijayagopal P; Figueroa JE; Martin DH
    Infect Immun; 1997 Feb; 65(2):503-6. PubMed ID: 9009304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
    Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R
    Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.